Kebilidi is the first gene therapy approved by the FDA for administration directly into the brain, given via a cannula during a surgical procedure, and replaces the human dopa decarboxylase (DDC ...
Hosted on MSN1mon
Mike Slive Foundation Awards 6 prostate cancer research grantsTargeting dopa decarboxylase (DDC)-dependent metabolic reprogramming to overcome immunotherapy resistance in NEPC, Dr. Guocan Wang, The University of Texas MD Anderson Cancer Center. Investigating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback